December 16, 2024 BiotechTrending MindMed Initiates Phase 3 Trial of MM-120 for Generalized Anxiety Disorder
December 16, 2024 Biotech Reviva’s Brilaroxazine Demonstrates Promising Results for Schizophrenia in Long-Term Study
December 12, 2024 BiotechFeatured Unsupported drug prices add $815 million to U.S. Healthcare costs in 2023, ICER reports
November 28, 2024 BiotechTrending Trump’s Healthcare Appointments and Their Implications for the Pharmaceutical Industry
November 27, 2024 Biotech Kane Biotech Partners with BioStem for U.S. Distribution of revyve™ Antimicrobial Wound Gel
November 27, 2024 Biotech Jay Bhattacharya Tapped as NIH Director: A Shift in U.S. Health Policy Leadership
